The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma

Table 5

The enriched pathways of the 206 genes that negatively correlated with HRAS but positively correlated with KRAS and NRAS expression.

Term	KEGG pathway	value
hsa05220	Chronic myeloid leukemia	0.004
hsa05215	Prostate cancer	0.008
hsa04810	Regulation of actin cytoskeleton	0.011
hsa05221	Acute myeloid leukemia	0.014
hsa04110	Cell cycle	0.024
hsa03040	Spliceosome	0.024
hsa05212	Pancreatic cancer	0.025
hsa04010	MAPK signaling pathway	0.029
hsa04350	TGF-beta signaling pathway	0.041